Company / Free Cash Flow per Share
Haemonetics Free Cash Flow per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.98
FY2026
5-year range
$1.59 / $2.98
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#59 of 148
Health Care
What the data says
At $2.98, Haemonetics's free cash flow per share ranks #59 of 148 in the Health Care sector. Free Cash Flow per Share has increased for 5 consecutive years, from $1.40 in FY2020 to $2.98 in FY2026.
Based on SEC 10-K filings.
2.98 in FY2026 with a 5-year CAGR of +15.1%.
Improved from $2.79 to $2.98 over the past 3 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#59 of 148 in Health CareTop 40% of 148This company $2.98 Sector average $5.04
▼
-40.9% below sector average
Key checks
Key Insights
- Ranks #59 out of 148 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2018.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.98 | - |
| FY2025 | - | - |
| FY2024 | $2.82 | +1.0% |
| FY2023 | $2.79 | +75.8% |
| FY2022 | $1.59 | +7.7% |
| FY2021 | $1.48 | +5.4% |
| FY2020 | $1.40 | -33.8% |
| FY2019 | $2.11 | +173.8% |
| FY2018 | $0.77 | -73.0% |
| FY2017 | $2.86 | +76.6% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026